NYMU Taipei/Part List
From 2007.igem.org
(Difference between revisions)
Line 5: | Line 5: | ||
!Description | !Description | ||
!length | !length | ||
- | !plasmid | + | !plasmid (antibotics) |
|- | |- | ||
|[http://partsregistry.org/Part:BBa_R0082 BBa_R0082] | |[http://partsregistry.org/Part:BBa_R0082 BBa_R0082] | ||
Line 55: | Line 55: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | | | ||
+ | |IDE | ||
+ | |2 | ||
+ | |insulin degradation enzyme | ||
+ | | | ||
+ | |C | ||
+ | |- | ||
+ | | | ||
+ | |IGFBP3 | ||
+ | |2 | ||
+ | |Insulin-like growth factor binding protein 3 | ||
+ | | | ||
+ | |C | ||
|} | |} |
Revision as of 06:14, 16 August 2007
Part Name | alias | Circuit | Description | length | plasmid (antibotics) |
---|---|---|---|---|---|
[http://partsregistry.org/Part:BBa_R0082 BBa_R0082] | pOmpC | 1 | Positively regulated, OmpR-controlled promoter | 108 | pSB1A2 |
[http://partsregistry.org/Part:BBa_B0034 BBa_B0034] | RBS | 1,2,3 | The Elowitz RBS (Ribosome binding site) is the definition of efficiency 1.0 | 12 | pSB1A2 |
N/A | INS_A | 1 | alpha chain of human insulin | 63 | N/A |
N/A | INS_B | 1 | beta chain of human insulin | 90 | N/A |
[http://partsregistry.org/Part:BBa_B0014 BBa_B0014] | D-term | 1,2,3 | Double translation terminator | 95 | pSB1AK3 |
[http://partsregistry.org/Part:BBa_I14032 BBa_I14032] | pLacIQ | 2 | Constitutive Promoter, High Transcription | 37 | pSB2K3 |
OmpRBS | 2 | OmpR binding sites | |||
IDE | 2 | insulin degradation enzyme | C | ||
IGFBP3 | 2 | Insulin-like growth factor binding protein 3 | C |